1 terminated, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Withdrawn 1 |
Follow Cytokines: new trials by email Literature Review of Cytokines trials Research Report on Cytokines
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Study of the Site for Growth Factor Injection for Patients Undergoing Autologous Stem Cell Transplantation G-CSF, GM-CSF administered at extremities, G-CSF and GMCSF administered at abdomen - Cytokines | Phase 2 | Terminated | Emory University | 35 | 2008-04-01 | 2025-04-01 |
| Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome Mesalamine, Infliximab, Corticosteroids - Hermanski-Pudlak Syndrome, Colitis | Phase 2 | Withdrawn | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-08-07 | 2017-07-02 |
Colitis (1) · Hermanski-Pudlak Syndrome (1)
Albinism (1) · Albinism, Oculocutaneous (1) · Amino Acid Metabolism, Inborn Errors (1) · Blood Coagulation Disorders (1) · Blood Coagulation Disorders, Inherited (1) · Blood Platelet Disorders (1) · Colonic Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1) · Eye Diseases (1) · Eye Diseases, Hereditary (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1)
Adalimumab (1) · Adrenal Cortex Hormones (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Infliximab (1) · Intercellular Signaling Peptides and Proteins (1) · Mercaptopurine (1) · Mesalamine (1) · Tacrolimus (1) · sargramostim (1)
Emory University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (2)